Post by Yelk on Jun 24, 2015 4:14:39 GMT
Jun 18, 2015 1:04:04 GMT JHam said:
I know nothing about this company, but $63M raised, 4.5M shares at $14 with no warrants. Plus they up-list to the Nasdaq tomorrow. Gotta like that. Good luck! Sounds like P3 data and NDA expected in 2016, should be interesting.
- $30 million to fund the Phase 3 program (CTH-300, CTH-301, CTH-200)
- $25 million to fund pre-approval commercialization efforts in the U.S.
- $12 million to initiate clinical and regulatory activities in the EU
- $5 million to complete CMC related expenses
- $3 million to fund early-stage pipeline development
Basically the first funding was natural funding for company operations. The recent uplist and reverse stock split and offering is the company saying they want to go it alone. If a buyout offer comes 3-4X upside (which is very likely for this) then the company will be in an excellent position to negotiate a higher sale price. I am pleased with this either way as if they go it alone successfully will generate good value and if we do get snatched up we can get a nice bonus from better negotiation.
The science behind this is very compelling and their product is safer, easier to use and more effective than the similar company that got purchased. The due diligence is well worth the time for this company. I don't know where the stock price is going next few months which is why I don't have a full size position but I know in 2016 it will be a hell of a lot higher than it is today and that is my focus. 50% now and will add 10% portions on any good dips.